CTLA4 and Schwartz-Jampel syndrome: More cases of TEN were reported than those of SJS caused by ICI combination therapy, in contrast to the cases resulting from the single use of PD‐1 or CTLA‐4 inhibitors (Figure 1d,e), probably indicating an association between the stronger immunological stimulation by combination therapy and the severity of SJS/TEN.